Our latest industry report analyses the healthcare software M&A market, considering the transformational impact of Covid-19 on the sector and the factors driving accelerated market growth, investment activity and historically high exit valuations.
Software M&A activity has rebounded to its highest level since Q120. The sector has witnessed accelerated consolidation activity and heightened interest from private equity investors who have realigned their investment strategies and attention towards pandemic resilient business models in order to navigate Covid-19. Healthcare software companies have reacted swiftly to the pandemic by altering inorganic growth plans, devising M&A strategies focused on augmentation of technologies, ease of scalability and expansion of market share. In turn, shareholders have benefitted from heightened valuations, with well capitalised acquirers willing to pay substantial premiums in order to maintain competitive advantage and access new technologies.
To read the full report, click here.